People with colorectal cancer obtaining treatments in the advanced stages as delay in detection of cancers. By this rate of colorectal cancer deaths increased.
New guidelines initiated by The American Cancer Society for colorectal cancer has suggested adults to take screen test at age of 45 to overcome risk. In the past recommended to undergo test at the age of 50. However, the high risk of rectal cancer observed in African Americans, Alaska Natives and people with a genetic disorder imply early screening. The second major cancer related deaths among children, adults in US.
According to the WHO, the third most common cause of cancer-related deaths in the world. As colorectal cancer involves both colon and rectal cancers. Moreover, the rate of colorectal cancer increasing in American people with age below 50.
Colorectal Cancer study model MISCAN
The researchers also commissioned a microsimulation modeling study involving a model called MISCAN, which simulates colorectal cancer incidence and mortality and estimates risk factors and the impact of screening and treatment practices.
Researchers based on study identified the strategies of screening to perform at the age of 45. Moreover, those strategies were undergoing colonoscopy every 10 years. A computed tomography colonography or “virtual colonoscopy” every five years. A flexible sigmoidoscopy every five years. A multitarget stool DNA test every three years. A take-home fecal immunochemical test annually or a take-home high-sensitivity guaiac fecal occult blood test annually.
As per guidelines there is cost variation among the screening. It depends upon the insurance plans which patients opted. The screening starts at the range of $30, up to thousands of dollars for colonoscopy. consumers should understand what their individual insurance policy will cover should they begin screening at age 45, rather than age 50.